By participating in NLRP3 and NF-kB related signalling pathways, empagliflozin, a new hypoglycaemic drug that can improve the prognosis of CVDs, can attenuate ferroptosis, fibrosis, apoptosis, and inflammation in doxorubicin-treated mice and significantly improve cardiac function, thereby opening up a new avenue for the treatment of doxorubicin-related cardiotoxicity [150, 151]
C.ValeO
Traditional medicine often struggles to address multi-system, energy-limiting illnesses, leaving many patients feeling dismissed or overwhelmed by the burden of researching their own care
Personalized care plans may include lifestyle guidance and medically appropriate options
The High-Dose Protocol may offer the most dramatic benefits, but the Ukrainian and Russian Protocols are excellent for maintenance or first-time users
Our findings highlight the pivotal role of astrocytic GABA in PTSD pathophysiology and establish MAOB inhibition as a mechanistically targeted approach to alleviate symptoms